Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2012
Event: Entry into an Underwriting Agreement for a public offering of senior notes.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, or margins. The primary financial data disclosed relates to a capital raising event:
- Debt Issuance: $1,250,000,000 aggregate principal amount of 5.750% Senior Notes due 2022.
- Interest Rate: 5.750%.
- Maturity Date: 2022.
- Underwriter: J.P. Morgan Securities LLC (as representative).
Material Changes and Transaction Details
The filing discloses a material change in the company's capital structure and liquidity position pending the closing of the offering:
- Purpose of Proceeds: To finance a portion of the cash consideration for DaVita's merger with HealthCare Partners Holdings, LLC (HCP).
- Expected Closing: August 28, 2012, subject to customary conditions.
- Escrow Arrangement: Net proceeds will be deposited into escrow upon closing.
- If the merger with HCP is consummated by the "Escrow End Date" (November 30, 2012, subject to three one-month extensions), funds will be released to DaVita.
- If the merger is not consummated or DaVita elects not to pursue it, the escrowed funds will be used to redeem the Notes at a special mandatory redemption price.
Guidance, Risks, and Contingencies
Contingencies: The release of funds for the merger is contingent upon the satisfaction of conditions to the merger with HCP by the Escrow End Date. Failure to meet these conditions triggers a mandatory redemption of the Notes.
Risks: The transaction is subject to customary market and closing conditions. The filing incorporates by reference the Underwriting Agreement and a press release for complete terms.
Management Commentary: The filing text does not contain direct management commentary beyond the description of the transaction mechanics.
Investor Verification Checklist
- Verify the final closing date of the $1.25 billion note offering (expected August 28, 2012).
- Confirm the status of the merger agreement with HealthCare Partners Holdings, LLC (HCP).
- Review the specific terms of the "special mandatory redemption price" in the Underwriting Agreement (Exhibit 1.1).
- Monitor the Escrow End Date (November 30, 2012) and any potential extensions.
- Check the press release (Exhibit 99.1) for additional details on the offering pricing and market reception.